Targeting cancer stem cells with ALDH1A1-based immunotherapy

Por DeLeo, Albert B.
Publicado em 2012

Development of multi-epitope vaccines targeting wild-type (wt) sequence p53 peptides

Por DeLeo, Albert B., Whiteside, Theresa L.
Publicado em 2008

Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules

Por Flood, Patrick M., DeLeo, Albert B., Old, Lloyd J., Gershon, Richard K.
Publicado em 1983

CD8+ T cell recognition of polymorphic wild-type sequence p53(65–73) peptides in squamous cell carcinoma of the head and neck

Por Andrade Filho, Pedro A., Ito, Daisuke, DeLeo, Albert B., Ferris, Robert L.
Publicado em 2010

p53 transformation-related protein: Detection by monoclonal antibody in mouse and human cells

Por Dippold, Wolfgang G., Jay, Gilbert, DeLeo, Albert B., Khoury, George, Old, Lloyd J.
Publicado em 1981

Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T-cell responses to HLA class I-restricted wild-type sequence p53 peptides

Por Sakakura, Koichi, Chikamatsu, Kazuaki, Furuya, Nobuhiko, Appella, Ettore, Whiteside, Theresa L., DeLeo, Albert B.
Publicado em 2007

SPONTANEOUS APOPTOSIS OF TUMOR-SPECIFIC TETRAMER(+) CD8(+) T LYMPHOCYTES IN THE PERIPHERAL CIRCULATION OF PATIENTS WITH HEAD AND NECK CANCER

Por Albers, Andreas E., Schaefer, Carsten, Visus, Carmen, Gooding, William, DeLeo, Albert B., Whiteside, Theresa L.
Publicado em 2009

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer

Por Chikamatsu, Kazuaki, Sakakura, Koichi, Takahashi, Goro, Okamoto, Atsushi, Furuya, Nobuhiko, Whiteside, Theresa L., DeLeo, Albert B., Masuyama, Keisuke
Publicado em 2009

Targeting cancer stem cells with p53 modulators

Por Zhang, Zhan, Liu, Ling, Gomez-Casal, Roberto, Wang, Xinhui, Hayashi, Ryo, Appella, Ettore, Kopelovich, Levy, DeLeo, Albert B.
Publicado no Oncotarget (2016)

Inhibition of soluble tumor necrosis factor prevents chemically-induced carcinogenesis in mice

Por Sobo-Vujanovic, Andrea, Vujanovic, Lazar, DeLeo, Albert B, Concha-Benavente, Fernando, Ferris, Robert L, Lin, Yan, Vujanovic, Nikola L
Publicado no Cancer Immunol Res (2016)

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer

Por Albers, Andreas E., Qian, Xu, Kaufmann, Andreas M., Mytilineos, Daphne, Ferris, Robert L., Hoffmann, Thomas K., DeLeo, Albert B.
Publicado no Sci Rep (2018)

Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8(+) T-cell-defined human tumor antigen of human carcinomas

Por Visus, Carmen, Ito, Diasuke, Dhir, Rajiv, Szczepanski, Miroslaw J., Chang, Yoo Jung, Latimer, Jean J., Grant, Stephen G., DeLeo, Albert B.
Publicado em 2011

17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

Por Szajnik, Marta, Szczepanski, Miroslaw J., Elishaev, Esther, Visus, Carmen, Lenzner, Diana, Zabel, Maciej, Glura, Marta, DeLeo, Albert B., Whiteside, Theresa L.
Publicado em 2012

Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide

Por Hendrickson, Ronald C., Cicinnati, Vito R., Albers, Andreas, Dworacki, Grzegorz, Gambotto, Andrea, Pagliano, Ornella, Tüting, Thomas, Mayordomo, Jose I., Visus, Carmen, Appella, Ettore, Shabanowitz, Jeffrey, Hunt, Donald F., DeLeo, Albert B.
Publicado em 2009

Targeting ALDH(bright) human carcinoma initiating cells with ALDH1A1- specific CD8(+) T cells

Por Visus, Carmen, Wang, Yangyang, Lozano-Leon, Antonio, Ferris, Robert L., Silver, Susan, Szczepanski, Miroslaw J., Brand, Randall E., Ferrone, Cristina R., Whiteside, Theresa L., Ferrone, Soldano, DeLeo, Albert B., Wang, Xinhui
Publicado em 2011

PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions

Por Szczepanski, Miroslaw J., DeLeo, Albert B., Łuczak, Michał, Molinska-Glura, Marta, Misiak, Jan, Szarzynska, Bronislawa, Dworacki, Grzegorz, Zagor, Mariola, Rozwadowska, Natalia, Kurpisz, Maciej, Krzeski, Antoni, Kruk-Zagajewska, Aleksandra, Kopec, Tomasz, Banaszewski, Jacek, Whiteside, Theresa L.
Publicado em 2012

Blocking the formation of radiation–induced breast cancer stem cells

Por Wang, Yangyang, Li, Wende, Patel, Shalin S., Cong, Juan, Zhang, Nan, Sabbatino, Francesco, Liu, Xiaoyan, Qi, Yuan, Huang, Peigen, Lee, Hang, Taghian, Alphonse, Li, Jian-Jian, DeLeo, Albert B., Ferrone, Soldano, Epperly, Michael W., Ferrone, Cristina R., Ly, Amy, Brachtel, Elena F., Wang, Xinhui
Publicado em 2014

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian can...

Por Rahma, Osama E., Ashtar, Ed, Czystowska, Malgorzata, Szajnik, Marta E., Wieckowski, Eva, Bernstein, Sarah, Herrin, Vincent E., Shams, Mortada A., Steinberg, Seth M., Merino, Maria, Gooding, William, Visus, Carmen, DeLeo, Albert B., Wolf, Judith K., Bell, Jeffrey G., Berzofsky, Jay A., Whiteside, Theresa L., Khleif, Samir N.
Publicado em 2011